Placebo-controlled,Doubled,Randomized Trial Evaluating the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women Undergoing Laparoscopic Myomectomy
Phase 3
N/A
N/A
N/A
N/A
Open (Enrolling)
Female
Uterine Leiomyoma
Female
Uterine Leiomyoma
Trial Information
Placebo-controlled,Doubled,Randomized Trial Evaluating the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women Undergoing Laparoscopic Myomectomy
Inclusion Criteria:
- uterine myoma
- be planning to laparoscopic myomectomy
- images ; the number of myoma <4
- images ; the diameter of the largest myoma <9cm
Exclusion Criteria:
- be planning other surgery in addition to laparoscopy
- clinically significant coagulation abnormality
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
blood loss
Outcome Time Frame:
during laparoscopic myomectomy
Safety Issue:
No
Principal Investigator
kiding kim, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Seoul National University Bundang Hospital,Gyeongg-ido,Republic of Korea
Authority:
Korea: Institutional Review Board
Study ID:
SNUBH_GO_016
NCT ID:
NCT01715597
Start Date:
December 2012
Completion Date:
January 2014
Related Keywords:
- Uterine Leiomyoma
- uterine leiomyoma
- laparoscopic myomectomy
- intraoperative blood loss
- ascorbic acid
- Hemorrhage
- Leiomyoma
- Myofibroma
Name | Location |
|---|
